Morgan Stanley Rule 8.1(b)(i) - ABBVIE INC. (4235I)
08 Agosto 2019 - 7:28AM
UK Regulatory
TIDM43CT
RNS Number : 4235I
Morgan Stanley
08 August 2019
Ap9
APPENDIX 3
DISCLOSURE FORMS
FORM 8.1(a)&(b)(i)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER
PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH
THEM FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS
1. KEY INFORMATION
Name of person dealing Morgan Stanley Uruguay
(Note 1) Ltda.
Company dealt in ABBVIE INC.
======================
Class of relevant security US$0.01 COMMON STOCK
to which the dealings
being disclosed relate
(Note 2)
======================
Date of dealing 07 AUGUST 2019
======================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant security dealt in (Note 3)
Long Short
Number (%) Number (%)
=========== ===== =========== ======
(1) Relevant securities 2,474 0.00 2,674 0.00
================== ===================
(2) Derivatives (other
than options) 0 0.00 0 0.00
================== ===================
(3) Options and agreements
to purchase/sell 0 0.00 0 0.00
================== ===================
Total 2,474 0.00 2,674 0.00
================== ===================
(b) Interests and short positions in relevant securities of the
company, other than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
=========== ===== =========== ======
(1) Relevant securities 0 0.00 0 0.00
================== ===================
(2) Derivatives (other
than options) 0 0.00 0 0.00
================== ===================
(3) Options and agreements
to purchase/sell 0 0.00 0 0.00
================== ===================
Total 0 0.00 0 0.00
================== ===================
Ap10
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 5)
SALE 200 64.5500 USD
==================================== ===================
(b) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 6) securities unit
e.g. CFD (Note 7) (Note 5)
N/A N/A N/A N/A
====================== =================== ==========
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
N/A N/A N/A N/A N/A N/A N/A
============= =============== ========= ================ ====== =====================
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
N/A N/A N/A
=========================== ====================
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
N/A N/A N/A
============== =====================
Ap11
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person relating to the
voting rights of any relevant securities under any option referred
to on this form or relating to the voting rights or future
acquisition or disposal of any
relevant securities to which any derivative referred to on this
form is referenced. If none, this
should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 08 AUGUST 2019
Contact name Craig Horsley
=================
Telephone number +44(141) 245 7736
=================
Name of offeree/offeror ABBVIE INC.
with which acting in concert
=================
Specify category and nature Advisory
of acting in concert status
=================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ISECKFDDKBKDOFK
(END) Dow Jones Newswires
August 08, 2019 06:28 ET (10:28 GMT)
Morg St. 2032 (LSE:43CT)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Morg St. 2032 (LSE:43CT)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
